YouTube discussion (uploaded April 28, 2025 by Joy Kong, MD) exploring why regenerative medicine is costly. Speakers cite lack of acceptance by medical governing bodies, malpractice insurance difficulties, and contested claims about which biologics the FDA approves (a disputed "good old boys" narrative about autologous biologics).
I think another reason that the cost is higher is because it's not quite accepted by the governing bodies of medicine yet. So there's a risk that doctors are taking on when they do this. And also malpractice insurance coverage. That's a challenge for them, too.
It's an extreme challenge. As you know personally and as I know personally, there's a good old boys group that for many, many years has beat the same old worn out drum that the only FDA approved biologics are autologous biologics. And you and I have some very personal thoughts about that, having been both personally attacked. Because when you dig into the literature and you get granular in the literature, it's not there. The medicine isn't there. It's completely disingenuous the way it's being presented.
